Loading organizations...
§ Private Profile · San Jose, CA, USA
Novel long-read DNA sequencing technology
Key people at Loop Genomics.
Loop Genomics was founded in 2016 by Tuval Ben-Yehezkel (Founder/CEO).
Loop Genomics provides long-read sequencing solutions across a diverse set of research and clinical applications. Our platform for long-read DNA sequencing transforms short-read DNA sequencers into long-read sequencing machines.
Key people at Loop Genomics.
Loop Genomics was founded in 2016 by Tuval Ben-Yehezkel (Founder/CEO).
Loop Genomics is a biotechnology company specializing in synthetic long-read DNA sequencing technology that transforms existing short-read sequencers into long-read platforms through proprietary sample preparation and software. This hardware-free approach uses DNA barcoding to enable accurate, cost-effective, and scalable long-read sequencing, primarily serving genomic research, clinical, and microbiome applications. The technology enhances accessibility by allowing labs to leverage their current sequencing hardware for advanced long-read capabilities[1][2][5].
Founded in 2015 and headquartered in San Jose, California, Loop Genomics was acquired by Element Biosciences in 2022, integrating its long-read solutions into Element’s disruptive DNA sequencing platform. This acquisition positions Loop’s technology to broaden the scope and performance of sequencing applications, impacting research in human health, agriculture, and environmental genomics[1][3][4].
Loop Genomics was founded in 2015 by Tuval Ben-Yehezkel, who brought expertise in molecular biology and bioinformatics. The idea emerged from the need to overcome limitations in next-generation sequencing (NGS), particularly the inability of short-read sequencers to provide long-range genetic information without costly hardware upgrades. Loop’s innovation was to use molecular barcoding and software to reconstruct long DNA reads from short-read data, enabling more detailed and accurate genomic analysis without new sequencing machines[1][5][6].
Early traction included successful commercialization of products that delivered long-read resolution on existing short-read platforms, gaining recognition in microbial metagenomics and transcriptome sequencing. The pivotal moment came with the acquisition by Element Biosciences in 2022, which allowed Loop to scale its technology within a broader sequencing ecosystem[3][4].
Loop Genomics rides the trend of increasing demand for long-read sequencing to resolve complex genomic regions, structural variants, and microbial diversity that short reads alone cannot fully characterize. The timing is critical as genomics research and clinical diagnostics increasingly require comprehensive, high-resolution data at lower costs. Market forces such as the growth of precision medicine, microbiome research, and agricultural genomics favor technologies that enhance sequencing accuracy and accessibility.
By enabling long-read sequencing on widely available short-read platforms, Loop lowers barriers for labs to adopt advanced genomic analyses, thus democratizing access and accelerating discoveries. Its integration into Element Biosciences’ platform exemplifies a shift toward versatile, multi-modal sequencing systems that can serve a broad ecosystem of researchers and diagnostic developers[2][3][4].
Looking ahead, Loop Genomics is poised to expand its impact through Element Biosciences’ growing sequencing platform, potentially driving adoption of combined short- and long-read sequencing in research and clinical markets. Trends shaping its journey include the push for more comprehensive genomic data, cost reduction in sequencing workflows, and the rise of multi-omics approaches.
As sequencing technology evolves, Loop’s software-driven, hardware-free model may influence broader industry standards by emphasizing flexibility, scalability, and integration. Its role in enabling affordable long-read sequencing could catalyze new applications in genomics, personalized medicine, and environmental biology, fulfilling the promise of next-generation sequencing with enhanced resolution and accessibility[4][3].
